Effect of nalbuphine on patient controlled intravenous analgesia after radical resection of colon cancer

  • Authors:
    • Qi Jiang
    • Rongfang Zhang
    • Tao Liu
  • View Affiliations

  • Published online on: January 24, 2020     https://doi.org/10.3892/ol.2020.11259
  • Pages: 2533-2538
  • Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Effect of nalbuphine on patient‑controlled intravenous analgesia (PCIA) after radical resection of colon cancer was explored. Retrospective analyses of 100 patients who underwent elective laparoscopic radical resection of colon cancer in Xiang Yang No. 1 People's Hospital, Hubei University of Medicine from June 2014 to December 2016 were made. Forty-seven patients were treated with nalbuphine as experimental group and 53 cases were treated with morphine as control group. All patients received PCIA after surgery. According to visual analogue scale (VAS), pain degree at 2, 4, 8, 12 and 24 h after surgery, total dosage of analgesia pump, total times and effective times of pressing were evaluated. Analgesic satisfaction rate, and adverse reactions such as nausea, vomiting, dizziness and headache at the same time were observed and recorded. The postoperative VAS in the experimental group was evidently lower than that in the control group (P<0.05) at 8, 12 and 24 h after surgery, which was statistically significant. There was no significant difference in postoperative VAS between experimental group and control group at 2 and 4 h after surgery (P>0.05). The incidence of adverse reactions to nausea and vomiting in the experimental group was low. There was no significant difference in the total dosage of analgesia pump, total times and effective times of pressing and analgesic satisfaction rate (P>0.05). After laparoscopic radical resection of colon cancer, nalbuphine is effective in PCIA, with low incidence of adverse reactions and high safety.

Related Articles

Journal Cover

March 2020
Volume 19 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Jiang, Q., Zhang, R., & Liu, T. (2020). Effect of nalbuphine on patient controlled intravenous analgesia after radical resection of colon cancer. Oncology Letters, 19, 2533-2538. https://doi.org/10.3892/ol.2020.11259
MLA
Jiang, Q., Zhang, R., Liu, T."Effect of nalbuphine on patient controlled intravenous analgesia after radical resection of colon cancer". Oncology Letters 19.3 (2020): 2533-2538.
Chicago
Jiang, Q., Zhang, R., Liu, T."Effect of nalbuphine on patient controlled intravenous analgesia after radical resection of colon cancer". Oncology Letters 19, no. 3 (2020): 2533-2538. https://doi.org/10.3892/ol.2020.11259